Recommendation:
NewvoDrug
is indicated for initial treatment of
cardiac failure
for all adult patients.
(Strong recommendation;
Class I,
based on
multiple randomized clinical trials)
Contraindication:
cardiac failure should never
be treated with
appendectomy in adults.
(Class III,
standard of care)